| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/26/2004 | EP1165104B1 Lactobacillus parcasei strain capable of preventing diarrhoea |
| 05/26/2004 | EP1140122B1 Pro-apoptotic agents |
| 05/26/2004 | EP0969851B1 Immunomodulatory complex and use thereof in helicobacter diseases |
| 05/26/2004 | EP0894129B1 Short external guide sequences |
| 05/26/2004 | CN1500147A Improved gene expression |
| 05/26/2004 | CN1500096A Osteoprotegerin in milk |
| 05/26/2004 | CN1499978A Manufacture of hemoglobin-based oxygen carrier |
| 05/26/2004 | CN1499976A Caloporoside derivatives, methods for prodn. thereof and their use |
| 05/26/2004 | CN1498655A Hemostat and its usage |
| 05/26/2004 | CN1498627A New usage of strain of lactobacillus for curing irritability |
| 05/26/2004 | CN1498610A Asynchronous method for health of mouth cavity daily |
| 05/26/2004 | CN1498552A Method for preparing nutritious health food of soft capsule of composite yolk lecithin |
| 05/26/2004 | CN1498545A Diet therapy milk powser candy for diabetes and its preparing method |
| 05/26/2004 | CN1151170C Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/26/2004 | CN1150933C Chinese medicine for treating prostatitis, prostate hyperplasia and prostatauxe |
| 05/26/2004 | CN1150928C Medicine for curing cancers and its prepn. method |
| 05/26/2004 | CN1150927C Stomatopathy and throat disease treating health care medicine and its production process |
| 05/26/2004 | CN1150926C Medicine for treating hepatitis B and cirrhosis |
| 05/26/2004 | CN1150925C Chinese Patent medicine for curing deafness |
| 05/26/2004 | CN1150923C Medicine for treating stomatocase |
| 05/26/2004 | CN1150922C Medicated wine for treating rheumatism, rheumatoid disease and other arthralgia |
| 05/26/2004 | CN1150921C Medicine for treating algia disease and its preparing process |
| 05/26/2004 | CN1150920C Medicine for treating female dimacteric syndrome and its preparing process |
| 05/26/2004 | CN1150919C Paste for eradicating liver disease and preparing method |
| 05/26/2004 | CN1150916C Fish medicine for preventing fish from raising nose above water |
| 05/26/2004 | CN1150915C Prescription of'strong heart first-aid dropping pill'and its preparing process |
| 05/26/2004 | CN1150911C Freeze-dried scorpion processing method |
| 05/26/2004 | CN1150910C Instant bee pollen and its preparing process |
| 05/26/2004 | CN1150909C Medicine for treating cerebral thrombus and its preparing process |
| 05/26/2004 | CN1150908C Prodn. method of seahorse powder capsule |
| 05/26/2004 | CN1150907C Usage of turtle oil, and trionxy oil |
| 05/25/2004 | USRE38522 Demineralized lyophilized allograft bone powder in a n,o-carboxymethylchitosan water carrier solution |
| 05/25/2004 | US6740750 Ribozyme sequences related to hiv resistance |
| 05/25/2004 | US6740493 Quantifying the amount of osteocalcin/osteonectin to identify bone disorder risk; useful in the treatment of bone disorders and diseases, such as osteoporosis, and in promoting fracture repair |
| 05/25/2004 | US6740484 Method of cryopreservation of tissues by vitrification |
| 05/25/2004 | US6740334 Bone resorption suppressing agent |
| 05/25/2004 | US6740320 Recombinant P53 adenovirus methods and compositions |
| 05/25/2004 | US6740239 Centrifuge machine containing one or more suspended product bags that can be oscillated forwards and backwards for dilution of blood concentrates |
| 05/25/2004 | CA2342283C Recombinant adenovirus for tissue specific expression in heart |
| 05/21/2004 | WO2004042039A1 Induction of ctla-4 upregulation in t lymphocytes |
| 05/21/2004 | WO2004042038A1 Method for the treatment of diseased, degenerated, or damaged tissue using three-dimensional tissue produced in vitro in combination with tissue cells and/or exogenic factors |
| 05/21/2004 | WO2004042033A2 Circulating stem cells and uses related thereto |
| 05/21/2004 | WO2004042018A2 Dopamine neurons from human embryonic stem cells |
| 05/21/2004 | WO2004041305A1 Method for inhibiting yeast growth |
| 05/21/2004 | WO2004041172A2 Interferon antagonists useful for the treatment of interferon related diseases |
| 05/21/2004 | WO2004041071A2 Compositions, systems, and methods for focusing a cell-mediated immune response |
| 05/21/2004 | WO2004022709A3 Epitope sequences |
| 05/21/2004 | WO2004018652A3 Method for obtaining diploid, pluripotential stem cells and use thereof |
| 05/21/2004 | WO2003050249B1 Islet cells from human embryonic stem cells |
| 05/21/2004 | WO2003015724A8 Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof |
| 05/21/2004 | WO2002088337A9 Olfactory ensheathing glia produced by introducing telomerase |
| 05/21/2004 | WO2002067862A3 Regulation of the ctl response by macrophage migration inhibitory factor |
| 05/21/2004 | WO2002061105A8 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 05/21/2004 | WO2000066068A3 Method for inducing growth and enhancing survival of nervous tissue |
| 05/21/2004 | CA2543376A1 Interferon antagonists useful for the treatment of interferon related diseases |
| 05/21/2004 | CA2502722A1 Method for inhibiting yeast growth |
| 05/21/2004 | CA2473776A1 Method for the treatment of diseased, degenerated, or damaged tissue using three-dimensional tissue produced in vitro in combination with tissue cells and/or exogenic factors |
| 05/20/2004 | US20040097867 Systems and methods for treating patients with processed lipoaspirate cells |
| 05/20/2004 | US20040097862 Bag system for the cryopreservation of body fluids |
| 05/20/2004 | US20040097714 Using microfiltration and/or diafiltration to isolate transforming growth factor from dairy products for use in treatment and prevention of cell proliferative, autoimmune, bone and inflammatory disorders; antitumor agents |
| 05/20/2004 | US20040097705 Small acid-soluble spore protein and uses thereof |
| 05/20/2004 | US20040097703 Cancer antigen peptide for treatment cell proliferative and cancer disorders |
| 05/20/2004 | US20040097469 For prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans |
| 05/20/2004 | US20040097464 Mixture of non-sulfated fucose-based oligosaccharides, a cosmetic or pharmaceutical composition comprising said mixture and its use in cosmetics or pharmacy |
| 05/20/2004 | US20040097455 Cloning of reporter genes and cDNA encoding for therapeutic proteins for the treatment of hepatic, pulmonary, renal, heart, pancreas fibrosis, keloids and hypertrophic scars, in mammals, including human beings |
| 05/20/2004 | US20040097415 Controlling blood glucose concentration; amylin antagonist |
| 05/20/2004 | US20040097412 Non-mammalian GnRH analogs and uses thereof in tumor cell growth regulation and cancer therapy |
| 05/20/2004 | US20040096971 Using cortical and/or medullary thymic epithelial cells to propagate lymphocytes and generate T cells from hematopoietic stem cells |
| 05/20/2004 | US20040096939 Modifier of organelle metabolism |
| 05/20/2004 | US20040096843 Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules |
| 05/20/2004 | US20040096517 Drug obtained from reverse chromatography of human urine; extraction; purification |
| 05/20/2004 | US20040096434 Agent for relieving intestinal disorders comprising live bacterial cells of a strain belonging to Lactobacillus helveticus, wherein said strain exhibits minimum growth inhibitory concentration of 0.8% or more dry solid bile in a |
| 05/20/2004 | US20040096432 System for the cell-specific and development-specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells |
| 05/20/2004 | US20040096431 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 05/20/2004 | US20040096427 Method of preventing gastro-intestinal dysfunction comprising orally administering a Gram (+) bacteria and glutamine composition. Gram (+) bacteria and glutamine composition for vaccines |
| 05/20/2004 | US20040096426 Compositions and methods for identifying antigens which elicit an immune response |
| 05/20/2004 | US20040096425 Method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitising agent, the cell is irradiated with light of a wavelength effective to activate the photosensitising agent and, substantially at the |
| 05/20/2004 | CA2412414A1 Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof |
| 05/19/2004 | EP1420065A1 Process for producing inactivated virus envelope |
| 05/19/2004 | EP1419779A1 Pharmaceutical composition inducing cancer cell differentiation and their use for treatment and prevention of cancer |
| 05/19/2004 | EP1419768A1 Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction |
| 05/19/2004 | EP1419257A1 Methylation resistant vectors |
| 05/19/2004 | EP1419245A2 Pseudotyped adeno-associated viruses and uses thereof |
| 05/19/2004 | EP1419241A2 Improved nitroreductase enzymes |
| 05/19/2004 | EP1418941A2 Vaccination against the feline immunodeficiency virus |
| 05/19/2004 | EP1418940A2 Dna expression vectors and methods of use |
| 05/19/2004 | EP1418927A1 Cell compositions for use in the treatment of osteo-arthrosis, and method for producing the same |
| 05/19/2004 | EP1418926A2 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and their use in bone marrow transplantation |
| 05/19/2004 | EP1418866A2 Xenograft bone matrix for orthopedic applications |
| 05/19/2004 | EP1418814A2 Production of transduced hematopoietic progenitor cells |
| 05/19/2004 | EP1304116A4 New class of bioactive glycoprotein |
| 05/19/2004 | EP1296695B1 Use of a polysaccharide excreted by the vibrio diabolicus species in bone repair |
| 05/19/2004 | EP1261357A4 Isolation and transplantation of retinal stem cells |
| 05/19/2004 | EP1234024B1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 05/19/2004 | EP1171219B1 Biological fluid filter and system |
| 05/19/2004 | EP1124428A4 Stromal cell use |
| 05/19/2004 | EP1021553B1 Eukaryotic gene expression cassette and uses thereof |
| 05/19/2004 | EP1011734B1 Gene therapy vehicle comprising dermal sheath tissue |
| 05/19/2004 | EP0832253B1 Nucleic acid respiratory syncytial virus vaccines |
| 05/19/2004 | DE10250754A1 Production of composition with high ATP N-glycosidase and immunomodulatory activity, useful as antiinfective or anticancer drug, comprising material from marine sponges, e.g. Axinella polypoides |